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Autosomal dominant transmission 
of complicated hereditary spastic 
paraplegia due to a dominant 
negative mutation of KIF1A, SPG30 
gene
Chong Kun Cheon1,2, So-Hee Lim3, Yoo-Mi Kim1, Doyoun Kim4, Na-Yoon Lee3, Tae-Sung 
Yoon3, Nam-Soon Kim3, Eunjoon Kim  4,5 & Jae-Ran Lee  3
KIF1A is a brain-specific anterograde motor protein that transports cargoes towards the plus-ends of 
microtubules. Many variants of the KIF1A gene have been associated with neurodegenerative diseases 
and developmental delay. Homozygous mutations of KIF1A have been identified in a recessive subtype 
of hereditary spastic paraplegia (HSP), SPG30. In addition, KIF1A mutations have been found in pure 
HSP with autosomal dominant inheritance. Here we report the first case of familial complicated HSP 
with a KIF1A mutation transmitted in autosomal dominant inheritance. A heterozygous p.T258M 
mutation in KIF1A was found in a Korean family through targeted exome sequencing. They displayed 
phenotypes of mild intellectual disability with language delay, epilepsy, optic nerve atrophy, thinning of 
corpus callosum, periventricular white matter lesion, and microcephaly. A structural modeling revealed 
that the p.T258M mutation disrupted the binding of KIF1A motor domain to microtubules and its 
movement along microtubules. Assays of peripheral accumulation and proximal distribution of KIF1A 
motor indicated that the KIF1A motor domain with p.T258M mutation has reduced motor activity and 
exerts a dominant negative effect on wild-type KIF1A. These results suggest that the p.T258M mutation 
suppresses KIF1A motor activity and induces complicated HSP accompanying intellectual disability 
transmitted in autosomal dominant inheritance.
KIF1A is a motor protein that is expressed exclusively in the brain and transports cargoes from the cell body to 
peripheral ends of neurites1,2. Its motor domain is located at the N-terminus of the KIF1A molecule and uses ATP 
as energy sources for its movement along microtubules3,4. KIF1A transports synaptic vesicle precursors as well 
as dense-core vesicles through the C-terminal pleckstrin homology (PH) domain that binds phosphoinositides 
with high affinity and specificity5–8. When cargo-containing lipid vesicles bind to the PH domain, the KIF1A 
motor becomes a dimer through coiled-coils interactions located in the immediate downstream regions of the 
motor domain and gets activated for movements along the microtubules. Although KIF1A has been thought as 
a monomeric motor unlike other kinesin families, lines of evidence suggest that KIF1A can be converted into 
functional dimer9–12. KIF1A null mice display severe motor and sensory disturbances, and die within a day or 
so after birth5. In addition, evidences from mice indicate that KIF1A regulates hippocampal synaptogenesis and 
learning enhancement13.
Various heterozygous de novo missense mutations on the KIF1A motor domain have been identi-
fied in patients who display intellectual disability along with atrophy and spastic paraplegia14–17. In addition, 
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homozygous recessive mutations of KIF1A have been found in the hereditary sensory and autonomic neuropathy 
type 2 (HSANII) and in a recessive subtype of hereditary spastic paraplegia (HSP), SPG3018–21. More, recently, 
there have been two cases of autosomal dominant inheritance of KIF1A mutation; a de novo variant in the KIF1A 
motor domain (p.S69L) was transmitted dominantly from father to son with pure form of HSP, and the same 
heterozygous variant of KIF1A was identified in a family with a dominant segregation pattern of pure HSP22,23. 
Spastic paraplegia is characterized by progressive stiffness and contraction in the lower limbs. When additional 
symptoms or signs are present, the patients are diagnosed as ‘complicated’ rather than ‘pure’ spastic paraplegia. 
Complicated spastic paraplegia could be accompanied by systemic or neurologic abnormalities such as ataxia, 
seizures, intellectual disability, dementia, amyotrophy, extrapyramidal disturbance, or peripheral neuropathy24,25.
Here we report the first case of familial complicated HSP with a KIF1A mutation transmitted in autosomal 
dominant inheritance. This p.T258M mutation is located in the conserved sequences of the motor domain, and 
was identified from four patients in a family of HSP along with mild intellectual disability, language delay, optic 
nerve atrophy, thinning of corpus callosum, periventricular white matter lesion, microcephaly, and epilepsy. A 
structural modeling and assays using hippocampal neurons showed that this KIF1A mutation could bring about 
loss-of function of KIF1A motor and exert a dominant negative effect. It has been thought that the reduced repro-
ductive fitness in intellectual disability could make an autosomal dominant inheritance uncommon14. Therefore, 
this novel heterozygous p.T258M mutation with autosomal dominant inheritance is meaningful in that it expands 
the phenotypic spectrum of KIF1A variants to include intellectual disability and spastic paraplegia.
Results
Clinical Characteristics of Family with heterozygous variant in KIF1A. The pedigree for the family 
with KIF1A variant is shown in Fig. 1. All the enrolled family members were previously diagnosed with undi-
agnosed intellectual disability and spastic paraplegia. Clinical manifestations of patients with dominant KIF1A 
variant enrolled in this study were described in Table 1. Patient I.1, who was initially evaluated at the age of 35 
years, is a woman from South Korea with mild cognitive impairment, optic nerve atrophy, and peripheral sen-
sorimotor polyneuropathy affecting bilateral lower extremities. She underwent achilles tendon release operation 
due to spastic gait at age 17. On examination, she had both knee spasticity, Babinski reflex, and hyperreflexs on 
knees and ankles. She had increased tone and spasticity in the lower extremities with extensor plantar responses 
bilaterally. Family history is significant for her mother and two sisters with severe intellectual disability and spas-
tic paraplegia. Patient II.1, who was evaluated at the age of 10 years, is a first daughter of patient I.1. She presented 
with mild cognitive impairment and spastic paraplegia. She was unable to roll over and had poor head control at 
the age of 6 months. She could walk alone at the age of 21 months. Her language development was delayed so that 
she only spoke a few words. She was then diagnosed with optic nerve hypoplasia at the age of 10 years. On exami-
nation, she had microcephaly (head circumference <3rd percentile) and her reflexes were hyperactive. Brain MRI 
revealed thinning of corpus callosum and ill-defined lesion of periventricular white matter (Figs 2 and 3). She 
showed thoracolumbar scoliosis. Patient II.2, who is a 7-year-old-girl with tip-toe walking, is a second daughter 
of patient I.1. She could walk first time when she was 18 months old. She was obese (body mass index 98.4th 
percentile). On examination, she has deformities on ankles, widening popliteal angle, and anterior pelvic tilting. 
She also showed moderate cognitive impairment and dysarthria. Reflexes were hyperactive and her strength was 
within normal limits for her age. Ophthalmologic evaluation showed pale optic disc. Brain MRIs showed thinning 
of corpus callosum and ill-defined lesion of periventricular white matter. Patient II.3, a 5-year-old-boy, had both 
equinus deformity and walked with spastic gait. He had both knees spasticity, Babinski reflex, and hyperreflexs 
on knees and ankles, and had great function with his hands. He developed partial seizure attack when he was 4 
years old. Ophthalmologic examination showed pale optic disc. Brain MRIs showed thinning of corpus callosum 
and ill-defined lesion of periventricular white matter. He showed mild intellectual disability with speech delay.
Figure 1. Familial segregation of the KIF1A variant. Pedigree structure of a family with c.773C > T 
(p.Thr258Met) variant in KIF1A. Black symbols represent patients with KIF1A. Arrow indicates proband. Only 
participants in the study for whom DNA is available for analysis are numbered.
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Genetic Study. The study included 4 subjects from a non-consanguineous family presenting with cogni-
tive impairment, spastic gait, and negative test result for the spastic paraplegia 4 (SPG4) gene. In the next step, 
targeted exome sequencing (TES) in the four patients was applied using the Nextseq. 500 sequencing platform 
and TruSight One Sequencing panel (Illumina, USA) to identify the genetic cause of undiagnosed intellectual 
disability and spastic paraplegia. Written consent was obtained from the family for the blood samples. TES 
results revealed heterozygous novel variant, c.773 C > T (p.Thr258Met), on KIF1A exon 7 which was confirmed 
by Sanger sequencing (Fig. 4A). This variant is predicted to be damaging according to in silico analysis (SIFT 0, 
PolyPhen2 0.983, MutationTaster 1). The variant was not detected in control population (1000 genomes, ESP 
6500, and ExAC). The threonine at position 258 is a highly conserved amino acid residue among different species 
(Fig. 4B). Parental segregation was positive, indicating that the mutations occurred in a family.
Patient I.1 Patient II.1 Patient II.2 Patient II3 Nieh et al.16 Hotchkiss et al.17 Hotchkiss et al.17
KIF1A mutation c.773 C > T (T258M) c.773 C > T (T258M)
c.773 C > T 
(T258M)
c.773 C > T 
(T258M)
Various de novo 
missense mutations
c.595 G > A 
(G199R)
c.902 G > A 
(R307Q)
Gender Female Female Female Male 4 female, 2 male Male Male
Age (years) 35 10 7 5 1.5–16 6 14
Cognition & language Mild ID with language delay
Mild ID with 
language delay
Moderate ID 
with language 
delay
Mild ID with 
language delay
Severe global 
developmental delay
Severe cognitive 
impairment with 
language delay
Severe cognitive 
impairment with 
language delay
Ophthalmologic involvement Optic nerve atrophy Optic nerve hypoplasia Pale optic disks
Pale optic 
disks
3/6 Optic nerve 
atrophy 4/6 cortical 
visual impairment 
1/6 abnormal eye 
movements, 1/6 
cataracts
Nystagmus, pale 
optic disks Pale optic disks
Brain MRI nd
Thinning 
of corpus 
callosum
Thinning of 
corpus callosum
Thinning 
of corpus 
callosum
6/6 progressive cerebral 
and cerebellar atrophy
Thinning of corpus 
callosum, cerebellar 
Atrophy
Thinning of corpus 
callosum, cerebellar 
atrophy
Microcephaly nd Yes (<3rd percentile)
No (25th 
percentile)
No (10th 
percentile) 4/6 yes No (25th percentile) Yes (3rd percentile)
Contractures
Ankles(Achilles 
tendon release at age 
17yrs), knees, elbow
Elbows, 
ankles, knees Ankles, knees Ankles nd
Ankles(Achilles 
tendon release at 
age 6mo)
Elbows, ankles, 
knees
Spine Scoliosis Scoliosis Normal Normal nd Minor kyphosis Scoliosis
NCV testing
Sensorimotor 
polyneuropathy in 
lower extremities
nd nd nd nd
Axonal 
sensory-motor 
polyneuropathy
Distal motor 
neuropathy with 
absent sensory 
responses in 
upper and lower 
extremities
Epilepsy no no no yes 2/6 seizures 4/6 no seizures No yes
Table 1. Clinical manifestations of patients with KIF1A variant enrolled in this study as well as a summary of 
clinical characteristics in the three previous reports of patients with de novo KIF1A mutations. nd, not done.
Figure 2. Axial T2-weighted magnetic resonance image of patients. (A, Patient II.1; B, Patient II.2; C, Patient 
II.3) MRI shows thinning of corpus callosum on axial T2- weighted image which is shown in yellow arrow.
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Figure 3. Fluid-attenuated inversion recovery (FLAIR) magnetic resonance image of patients. (A, Patient II.1; 
B, Patient II.2; C, Patient II.3) FLAIR imaging shows ill-defined lesion of periventricular white matter which is 
shown in yellow circle.
Figure 4. Pathogenic mutation identified in KIF1A. (A) Direct sequencing of the proband and her family 
shows a novel heterozygous mutation of KIF1A gene, c.773C > T (p.Thr258Met). (B) The p.T258 amino acid 
is completely conserved across available different species which is shown in black box. Multiple amino acid 
sequence alignment was generated using Cluster Omega (http://www.ebi.ac.uk/Tools/msa/clustalo) and 
includes human (Homo sapiens; Q12756; UniprotKB), mouse (Mus musculus; E9QAN4; UniprotKB), chicken 
(Gallus gallus; F1NXK6; UniprotKB), Guinea pig (Cavia porcellus; H0VGT5; UniprotKB), Japanese rice fish 
(Oryzias latipes; H2L6W3; UniprotKB), and Mosquito (Anopheles sinensis; A0A084WAX1; UniprotKB).
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Structural impact of p.Thr258Met mutation on the motor domain of KIF1A. The crystal structure 
of the motor domain of KIF1A in complex with ADP and ATP analogues have been reported26,27. The results from 
these studies indicate that the binding and hydrolysis of ATP to the motor domain of KIF1A induce conforma-
tional changes in the motor domain that drive the movement of KIF1A along microtubules. The ATP-binding 
pocket in the KIF1A motor domain contains a P-loop (GX4GK[T/S]) and parts of the switch-1, and switch-2 
regions (Fig. 5A). The binding and hydrolysis of ATP to the KIF1A motor domain lead to conformational changes 
in switch-1 and switch-2. These changes allow for the loop 11 (L11) and the loop 12 (L12) in switch-2 alternatively 
Figure 5. Structural modeling of the KIF1A motor domain with p.T258M mutation. (A) Modelled structure of 
the KIF1A motor domain mutant (p.Thr258Met). The crystal structure of the motor domain from WT KIF1A 
in complex with ADP [PDB ID: 1I5S] is depicted as a cartoon representation. The ATP binding loop (P-loop), 
switch-1, and switch-2 are shown in green, deep blue, and purple, respectively. L11 and L12 (unmodelled) in 
switch-2 are also indicated. The ADP molecule is shown by the ball-and-stick model. The red box indicates 
a close-up view of the boxed region. The structure of the modelled mutant (p.Thr258Met) motor domain of 
KIF1A is shown in yellow. The conformational change in L11 predicted to be induced by the p.Thr258Met 
mutation is indicated by a red arrow, together with the structure of WT L11 shown in grey. (B,C) Electrostatic 
charge distribution patterns in the WT (B) and modelled mutant p.Thr258Met (C) motor domains of KIF1A, as 
shown by the surface model. Negative and positive charges are shown in red and blue, respectively. The regions 
of charge changes (L11) are indicated by red dotted circles.
www.nature.com/scientificreports/
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to bind to microtubules for KIF1A movement28. Therefore, L11 is important for ATP-dependent binding of 
KIF1A to microtubules for motor movement.
A structural modeling of the KIF1A motor domain containing the p.Thr258Met mutation showed that the 
point mutation leads to the disruption of the structure of L11 (Fig. 5A, red box). In addition structural alterations, 
the p.Thr258Met mutation caused changes in electrostatic charge distribution in L11, neutralizing the positive 
charges in L11, as shown by charge distribution patterns of wild-type (WT) and mutant motor domains of KIF1A 
(Fig. 5B,C). These results collectively suggest that the p.Thr258Met mutation disrupts both the conformation and 
electrostatic charge of L11 in the KIF1A motor domain, leading to the suppression of the binding of the mutant 
KIF1A protein to microtubules and hence causing limited motor movements along microtubules.
Functional impact of p.Thr258Met mutation on KIF1A motor activity. When EGFP tagged motor 
domain of WT KIF1A (aa 1–365, KIF1A-MD-EGFP) was expressed in rat hippocampal neurons, it was dra-
matically accumulated in distal regions of the neurites in a large proportion of the transfected cells10. However, 
induction of a point mutation (p.T312M) that impairs the motor activity resulted a greatly reduced peripheral 
accumulation of KIF1A motor domain proteins2,10. Previously we used this functional assay to test the impact of 
de novo missense mutations of KIF1A identified in patients with cognitive impairment15.
Using the same strategy, we expressed WT or mutant KIF1A-MD-EGFP (T258M) expression constructs in 
cultured hippocampal neurons and analyzed their localization in neurites (Fig. 6A). WT KIF1A-MD showed 
extensive peripheral accumulation (95.2%, 5 trials), but KIF1A-MD-T258M showed considerably reduced distal 
localization compared with WT (44.0%, 5 trials) (Fig. 6B). Interestingly, the impact of the p.T258M mutation 
on peripheral accumulation seemed to be intermediate between p.E253K of de novo mutation and p.A255V of 
autosomal recessive inheritance: KIF1A-MD-E253K (9.7%, 5 trials), KIF1A-MD-A255V (57.7%, 5 trials)15,20,21. 
Transfection of these constructs in HEK293 cells followed by Western blotting indicated that the mutant and WT 
KIF1A-MD proteins were expressed at similar levels (Supp. Fig. S1).
Previously we have reported that KIF1A-MD proteins with de novo mutations identified from patients with 
cognitive impairment are abnormally accumulated in the proximal regions of neuronal cell body15. Here, the 
proximal distribution of KIF1A-MD-T258M was increased considerably, as compared with WT proteins: WT 
KIF1A-MD (0.177, proximal neurite/soma, 6 trials), KIF1A-MD-T258M (0.490, proximal neurite/soma, 7 trials) 
(Fig. 6C). Similar to the results of the peripheral distribution test, p.T258M mutation had an impact on proximal 
distribution at levels between those of p.E253K and p.A255V: KIF1A-MD-E253K (0.564, proximal neurite/soma, 
6 trials), KIF1A-MD-A255V (0.407, proximal neurite/soma, 6 trials). These results suggest that the p.T258M 
KIF1A mutation identified in the family with autosomal dominant HSP exerts an intermediate impact on KIF1A 
motor activity, at the levels weaker than the p.E253K de novo mutation from cognitive impairment but stronger 
than p.A255V mutation from autosomal recessive HSP.
Dominant negative effect of p.Thr258Met mutation on WT KIF1A motor. The p.T258M mutation 
was identified as a heterozygous mutation, similar to de novo mutations found in patients with developmental 
delay. A dominant negative effect has been suggested to explain the phenotypes of de novo heterozygous muta-
tions that are more severe than those observed in patients with recessive mutations15. Because KIF1A could be 
converted into a functional dimer, we reasoned that any mutations of motor domain could exert dominant neg-
ative effect.
To this end, the peripheral distribution of WT KIF1A-MD was analyzed in the presence and absence of the 
co-expression with a mutant KIF1A-MD in hippocampal neurons (Fig. 7A,B). When KIF1A-MD-E253K was 
co-expressed, the peripheral accumulation of WT KIF1A-MD was dramatically reduced to the level of expression 
of KIF1A-MD-E253K only: WT KIF1A-MD (93.1%, 8 trials), KIF1A-MD-E253K (0.8%, 8 trials), WT KIF1A-MD 
with KIF1A-MD-E253K (7.4%, 8 trials). Co-expression of KIF1A-MD-T258M considerably reduced the dis-
tal localization of WT KIF1A-MD to levels similar to those of KIF1A-MD-T258M only: KIF1A-MD-T258M 
(35.1%, 8 trials), WT KIF1A-MD with KIF1A-MD-T258M (35.9%, 8 trials). Interestingly, KIF1A-MD-A255V 
exerted the dominant negative effect on KIF1A motor activity, but to lesser extent than KIF1A-MD-T258M: 
KIF1A-MD-A255V (53.24%, 8 trials), WT KIF1A-MD with KIF1A-MD-A255V (53.5%, 8 trials). These results 
suggest that all the tested KIF1A mutations could exert dominant negative effects on WT KIF1A, and the degrees 
of the dominant negative effects depend on the types of the mutations; strongest in the p.E253K de novo muta-
tion, intermediate in the p.T258M mutation of autosomal dominant inheritance, and weakest in the p.A255V 
mutation of autosomal recessive inheritance.
Discussion
In the present study, we identified a novel p.T258M mutation in KIF1A affecting mother and three children 
with spastic paraplegia that is inherited in a type of autosomal dominant manner. Previous studies have iden-
tified two cases of a dominantly inherited KIF1A variant (p.S69L) from pure HSP22,23. However, our patients 
with the p.T258M mutation in KIF1A displayed phenotypes of intellectual disability with language delay, optic 
nerve hypoplasia, thinning of corpus callosum, periventricular white matter lesion, microcephaly, and epilepsy 
in addition to spasticity. The inheritance of complicated HSP with intellectual disability has not been reported as 
far, and our p.T258M KIF1A mutation is the first case of autosomal dominant inheritance in familial complicated 
HSP (Table 2).
Deleterious heterozygous mutations of KIF1A in developmental delay have been suggested to act dominant 
negative effects, and this could explain their phenotype more severe than that those observed in patients with 
recessive mutations14,15. However, the molecular and cell biological evidence for the dominant negative effects 
could not be obtained because only mutant KIF1A-MD-EGFP proteins have been used to simply monitor protein 
accumulation at distal and proximal regions of neurites. Here, we attempted new strategy to evaluate dominant 
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Figure 6. Functional impact of p.T258M mutation on KIF1A motor activity. (A) KIF1A-MD-EGFP constructs 
were expressed in cultured hippocampal neurons and visualized by immunofluorescence staining with 
anti-EGFP antibody. WT KIF1A-MD accumulated in distal regions of the axons (arrow heads), but KIF1A-
MD-T258M showed a considerably reduced peripheral accumulation. The neuronal cell bodies (arrow) and 
dendrites were visualized by immunofluorescence staining for MAP2. (B) Quantification of the peripheral 
accumulation of KIF1A-MD (mean ± s.e.m.). The distal distribution of KIF1A-MD was analyzed as described 
in the methods section. Significant decreases are indicated (***p < 0.0001: **p < 0.001: *p < 0.05). (C) 
Quantification of the proximal distribution of KIF1A-MD (mean ± s.e.m.). The proximal distribution of 
KIF1A-MD was analyzed by measuring the brightness of the proximal neurites (blue asterisk) and the soma (red 
asterisk) as described in the methods section. Significant decreases are indicated (***p < 0.0001: *p < 0.05).
www.nature.com/scientificreports/
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negative effects: co-expression of WT KIF1A-MD with mutant KIF1A-MD in cultured hippocampal neurons 
followed by the evaluation of peripheral distribution. When co-expressed with mutants, WT KIF1A-MD showed 
dramatically reduced peripheral accumulation (Fig. 7). KIF1A-MD-T258M reduced the peripheral accumulation 
of WT KIF1A-MD effectively, although to a lesser extent than that exerted by KIF1A-MD-E253K carrying de 
novo mutation identified in global developmental delay with severe intellectual disability and to a great extent 
than the KIF1A-MD-A255V with a mutation from autosomal recessive HSP.
Figure 7. Dominant negative effect of p.T258M mutation on KIF1A motor activity. (A) WT KIF1A-MD-
EGFP showed considerably reduced peripheral accumulation when co-expressed with KIF1A-MD-T258M 
(arrow heads). Neuronal cell bodies (arrow) and dendrites were visualized by immunofluorescence staining 
for MAP2. (B) Quantification of the peripheral accumulation of KIF1A-MD proteins (mean ± s.e.m.). The 
distal distribution of KIF1A-MD was analyzed as described in Methods. Significant decreases are indicated 
(***p < 0.0001: *p < 0.05).
www.nature.com/scientificreports/
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It has been suggested that dimerization of KIF1A motors can induce dominant negative effects of heterozy-
gous KIF1A mutations14,15. Given that KIF1A can form dimers, autosomal recessive mutations may also exert 
dominant negative effects although likely more weakly. Our data indeed suggested that all the tested mutations in 
the motor domain can exert dominant negative effects on KIF1A motor activity: the p.E253K de novo mutation 
exerted the strongest dominant negative effect, and the p.A255V mutation of autosomal recessive inheritance 
exerted the weakest dominant negative effect, while the p.T258M mutation of autosomal dominant inheritance 
exerted an intermediate dominant negative effect.
Each mutation appears to exert various degrees of dominant negative effects according to their locations 
and charge properties of the mutated amino acids in the motor domain: e.g. acidic to basic one (Glu to Lys) in 
p.E253K de novo, polar to hydrophobic one (Thr to Met) in p.T258M autosomal dominant, and hydrophobic 
to hydrophobic one (Ala to Val) in p.A255V autosomal recessive. Notably, the severities of the charge change 
correlate with the impacts of the mutations on motor activity in the order of p.E253K, p.T258M, and p.A255V 
mutations.
It is likely that truncating mutations exert more deleterious phenotypes than point mutations. However, 
nonsense truncating mutations (p.L947Rfs*4 and p.S1758Qfs*7) of KIF1A from HSANII with peripheral nerve 
degeneration resulted autosomal recessive inheritance18. Their truncation mutations cause premature stop codons 
in the middle of the full-length KIF1A or in the C-terminal PH domain through which KIF1A associates with 
cargoes for synaptic transportation. It has been suggested that cargo-binding to the C-terminal PH domain could 
be the first step that initiates the dimerization and activation of KIF1A motor6,7. Therefore, a KIF1A truncation 
mutant without the PH domain is unlikely to disturb the function of WT KIF1A motor proteins, and exert an 
enough dominant negative effect to induce an autosomal dominant inheritance.
In conclusion, our data suggest that a novel heterozygous mutation (p.T258M) in KIF1A can induce HSP 
accompanying intellectual disability and this is the first case of familial complicated HSP transmitted in autoso-
mal dominant inheritance.
Methods
Subjects and Exome Sequencing Analysis. The study included 4 subjects from a non-consanguineous 
family from Korea presenting with cognitive impairment, spastic gait, and negative test result for the spastic para-
plegia 4 (SPG4) gene. Written informed consent was obtained from the family for the blood samples and the study 
was approved by the Institutional Review Board (IRB) of the Pusan National University Yangsan Hospital (IRB 
number: 05–20117–052). All experiments in this study were performed in accordance with the relevance guide-
lines. Library preparation was performed with a TruSight One Sequencing Panel Kit (Illumina, USA). This panel 
enriches for approximately 4,800 genes of clinical relevance. Massive parallel sequencing was conducted with a 
NextSeq. 500 sequencing instrument (Illumina, USA). Local realignment and recalibration were performed using 
the Genome Analysis Tool Kit (GATK version 3.30). Among the 7,853 called variants, 1,215 remained after filter-
ing for common variants with a minor allele frequency (1%) using multiple population databases (1000 Genomes 
Project, Exome Variant Server, and Exome Aggregation Consortium). Nucleotide numbering of the mutations 
herein reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the 
NCBI reference sequence NM_001244008.1, while the amino positions are based on the corresponding NCBI 
reference sequence NP_001230937.1. Prediction of the effects of the de novo missense KIF1A mutations on the 
protein function were done using PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) and SIFT (http://sift.jcvi.
org/), and MutationTaster (http://www.mutationtaster.org/), respectively.
Structural Modeling. Structural modeling of the KIF1A motor with p.Thr258Met mutation was performed 
using the crystal structure of the KIF1A motor domain in complex with ADP [PDB ID: 1I5S], which has a complete 
structure of L11, unlike other reported crystal structures of KIF1A with unmodelled L11 structure for the lack of 
electron density in this region. The p.Thr258Met point mutation was introduced to the KIF1A motor domain using 
Mutation Phenotype
Intellectual 
Disability Transmission Mutation Phenotype
Intellectual 
Disability Transmission
p.S58L Complicated Mild De novo p.R216C Complicated Severe De novo
p.S69L Pure spastic No Familial AD p.R216H Complicated Moderate De novo
p.T99M Complicated Yes/Severe De novo p.R216P Complicated Yes De novo
p.G102D Complicated Mild De novo p.L249Q Complicated Moderate De novo
p.G102S Complicated Mild Sporadic p.E253K Complicated Severe De novo
p.V144F Complicated Moderate De novo p.A255V Pure spastic** No Familial AR
p.R167C Complicated* Mild De novo p.T258M*** Complicated Moderate/Mild Familial AD
p.G199R Complicated Severe De novo p.R307Q Complicated Severe De novo
p.A202P Complicated Yes De novo p.R316W Complicated Mild De novo
p.S215R Complicated Yes De novo p.R350G Complicated No Familial AR
Table 2. Clinical phenotypes and inheritance patterns of patients with various missense mutations in the motor 
domain of KIF1A. *Another case of pure form reported15,23. **Another case of complicated form reported20,21. 
***New mutation identified in this study.
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the mutagenesis option in PyMOL, a molecular visualization software29. Energy minimization and loop flexible 
modeling were performed using Modeller software30. All structural images were generated using PyMOL29.
Analysis in Cultured Hippocampal Neurons. KIF1A mutation, p.T258M was introduced by 
site-directed mutagenesis into an expression construct encoding motor domain of mouse KIF1A (aa 1–365) 
(KIF1A-MD-EGFP)15. Primary cultured hippocampal neurons were prepared from rat embryonic brain as 
described previously10. This study was performed in accordance with the regulations outlined by the Korean 
law. The animal experiment protocols were approved by the Animal Use and Care Committee of Korea 
Research Institute of Bioscience and Biotechnology (Permit Number: KRIBB-AEC-16138). Animals were sac-
rificed using CO2 gas, and all efforts were made to minimize suffering. Using the calcium phosphate method, 
cultured hippocampal neurons were transfected with KIF1A-MD-EGFP. Five days after transfection, neurons 
were fixed and stained with anti-EGFP and anti-MAP2 antibodies followed by fluorescent secondary antibodies. 
Images were captured by a confocal microscope (LSM800, Zeiss) and analyzed using the MetaMorph software 
(Universal Imaging), as described previously15. Data were acquired from 5~6 trials for each mutant or wild type 
KIF1A-MD-EGFP and 10~15 images of neurons were collected for each trial. The methods about analyses of the 
peripheral accumulation and the proximal distribution were described previously15. The peripheral accumulation 
was quantified by calculating the number of neurons that show a distal distribution of the KIF1A-MD-EGFP over 
the total number of the transfected neurons in each trial. The proximal distribution was analyzed by measuring 
the brightness of the EGFP signal in the center of the neuronal cell body (soma) and in the segments of neurites 
(2~3/neuron) extending over 30 μm from the soma as described previously15. Then the ratio of the brightness in 
proximal neurites over the brightness in the soma in 6~8 neurons per trial was calculated. Statistical significance 
was assessed using the Student’s t-test. The dominant negative effects of KIF1A mutants were evaluated by analyz-
ing the peripheral accumulation of wild type KIF1A-MD-EGFP co-expressed with mutant KIF1A-MD-EGFP. For 
analysis of dominant negative effects, the same amounts of DNA expression constructs were transfected into rat 
hippocampal neurons, and then neurons were fixed and stained with primary antibodies followed by fluorescent 
secondary antibodies.
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